These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4156144)

  • 1. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
    Ban TA; Ananth JV; Lehmann HE
    Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomic component of the orienting reflex in schizophrenics.
    Saarma J
    Biol Psychiatry; 1974 Aug; 9(1):55-60. PubMed ID: 4457117
    [No Abstract]   [Full Text] [Related]  

  • 3. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phenothiazines on anxiety and cognition in schizophrenia.
    Meadow A; Donlon PT; Blacker KH
    Dis Nerv Syst; 1975 Apr; 36(4):203-8. PubMed ID: 234827
    [No Abstract]   [Full Text] [Related]  

  • 5. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 6. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep analysis during drug-free weekends in chronic schizophrenic patients.
    Jus K; Jus A; Béland C; Bouchard M; Pires P; Fontaine P; Brunelle R
    Biol Psychiatry; 1976 Dec; 11(6):709-18. PubMed ID: 187257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical effects of various schedules of medication.
    Chien CP; DiMascio A
    Behav Neuropsychiatry; 1971; 3(1):5-9. PubMed ID: 5566336
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):189-201. PubMed ID: 234359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with bromperidol in schizophrenic patients].
    Ellerman LA
    Acta Psiquiatr Psicol Am Lat; 1989; 35(1-2):23-30. PubMed ID: 2634329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized EEG: predictor of outcome in schizophrenia.
    Itil TM; Marasa J; Saletu B; Davis S; Mucciardi AN
    J Nerv Ment Dis; 1975 Mar; 160(3):118-203. PubMed ID: 1090708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
    Angelopoulos EK; Corcondilas M; Kollias CT; Kioulos KT; Bergiannaki JD; Papadimitriou GN
    J Clin Psychopharmacol; 2010 Dec; 30(6):745-6. PubMed ID: 21057243
    [No Abstract]   [Full Text] [Related]  

  • 15. Conditioned reflex analysis of chronic schizophrenias.
    Ananth JV; Lehman HE; Ban TA
    Can Psychiatr Assoc J; 1972 Oct; 17(5):377-89. PubMed ID: 4644786
    [No Abstract]   [Full Text] [Related]  

  • 16. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
    Müller P
    Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cortisol in chronic schizophrenia. Changes in the diurnal rhythm and psychiatric mental status on withdrawal of drugs.
    Franzĕn G
    Psychiatr Clin (Basel); 1971; 4(4):237-46. PubMed ID: 5134459
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot trials with long-acting pipotiazine injections.
    Hakola A
    Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.